Xueling Jiang

Title: Xueling Jiang - Innovator in Milbemycin Production

Introduction

Xueling Jiang is a notable inventor based in Hubei, China. He has made significant contributions to the field of pharmaceutical production, particularly in the development of high-yield strains for milbemycin. His innovative approaches have the potential to enhance production efficiency and reduce costs in industrial fermentation processes.

Latest Patents

Xueling Jiang holds a patent for a milbemycin strain with high-yield and its application. The patent describes a strain for high-yield production of milbemycin, specifically the original strain MI-W1-2017001, which has undergone mutation breeding using an atmospheric and room temperature plasma mutation method. This process has led to the development of a high-yield strain, HZMRYB-5. The fermentation level of this new strain is improved by approximately 70% compared to the original strain. Furthermore, through optimization of the fermentation process and formulation, the fermentation level is enhanced by an additional 35%. This innovation not only reduces the fermentation cost but also meets the industrial fermentation level requirements. The optimized fermentation process achieves a nearly 3:7 ratio of A3 and A4 in the fermentation liquid through mixed fermentation of strains MI-W1-2017001 and HZMRYB-5, significantly addressing market demands and simplifying the process steps of separation, purification, and mixing.

Career Highlights

Xueling Jiang is associated with Hubei Honch Pharmaceutical Co., Ltd., where he applies his expertise in pharmaceutical innovations. His work focuses on improving production methods and developing new strains that can lead to more efficient manufacturing processes.

Collaborations

Xueling Jiang collaborates with notable colleagues, including Renwen Zhang and Wenkai Zhang, who contribute to his research and development efforts. Their teamwork enhances the potential for innovative breakthroughs in the pharmaceutical industry.

Conclusion

Xueling Jiang's contributions to the field of milbemycin production exemplify the impact of innovative thinking in pharmaceuticals. His patented strain and optimized processes represent significant advancements that can benefit the industry and meet growing market demands.